Institutional investors hold a majority ownership of CELG through the 83.12% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2014, these large investors purchased a net $8.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JACKSON SQUARE PARTNERS LLC Bought 14.5 Million shares of Celgene Corp
FIDELITY MANAGEMENT & RESEARCH C... Bought 5.2 Million shares of Celgene Corp
JENNISON ASSOCIATES LLC Bought 2.7 Million shares of Celgene Corp